Table 1 Comparison of malignancy between 1PCa group and cPCa group
Characteristics | Latent prostate cancer | Clinical prostate cancer | P value | OR (95% CI) |
|---|---|---|---|---|
Total patient number | 24 | 126 | – | – |
Total lesion number | 45 | 429 | – | – |
Median age (IQR)/ (%) | 74 (64–77) | 71 (63–74) | 0.149 | 0.626 (0.698–1.174) |
ISUP grade ≥ 2 | 13 | 116 | < 0.001 | 10.39 (3.64–29.69) |
Tumor volume ≥ 0.5 ml | 3 | 104 | < 0.001 | 32.68 (8.95–119.36) |
EPE | 4 | 46 | < 0.001 | 6.54 (2.11–20.33) |
csPCa | 13 | 119 | < 0.001 | 14.65 (4.80–44.72) |